 |
||||||||||||||||
|
||||||||||||||||
|
||||||||||||||||
 |
||||||||||||||||
|
||||||||||||||||
 |
||||||||||||||||
|
||||||||||||||||
|
|
|
|
Stock data
| Last Trade | 9.38 | Trade Time | 5/22/2013 |
| Change |  -0.45
|
Volume (thou) | 284.2 |
| %Change | -4.58% | Last Trade Size | |
| Open | 9.82 | Bid | 9.38 |
| Today's High | 10.14 | Ask | 9.39 |
| Today's Low | 9.18 | Size Bid/Ask | 0 x0 |
Fundamental Data |
|||
| Market Cap (mil) | 263090.24 | 52 Week High | 12.70 |
| Shrs Outstanding (thou) | 28048000 | 52 Week Low | 4.00 |
| EPS | -1.27 | PE Ratio | .00 |
| Volatility | Yield | .00 | |
| Dividend Freq. | 0 | Ex-Dividend Date | 12:00:00 AM |
| Dividend Amount | 0 | Exchange | NASDAQ CM |
| Delayed quotes powered by S&P comstock. All stock quotes are delayed by 20 minutes and are believed to be accurate but are not warranted or guaranteed by MENAFN.com | |||
Related News
 |
May 10, 2013 | CORRECTION: Corrections, McClatchy-Tribune Information Services -- Unrestricted |
|
May 09, 2013 | Coronado Biosciences Inc's net loss widens to USD8.9m for Q1 2013, M2 |
|
May 08, 2013 | Coronado Biosciences Reports Financial Results for the First Quarter Ended March 31, 2013, GlobeNewswire |
|
May 07, 2013 | Coronado Biosciences Appoints Thomas F. Schaible, Ph.D. as Project Leader, Inflammatory Bowel Disease, GlobeNewswire |
|
May 06, 2013 | Coronado Biosciences to Present at the Bank of America Merrill Lynch 2013 Health Care Conference, GlobeNewswire |
|
May 01, 2013 | Coronado Biosciences to Report First Quarter 2013 Financial Results, GlobeNewswire |
|
Apr 25, 2013 | Coronado Biosciences Inc reports resignation of president Dr Bobby W Sandage Jr, M2 |
|
Apr 24, 2013 | Coronado Biosciences Announces Departure of Dr. Bobby W. Sandage, Jr., GlobeNewswire |
 more... |
||
